The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.

The impact and cost of scaling up GeneXpert MTB/RIF in South Africa.

We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa.We parameterised a population-level decision model...

Full description

Bibliographic Details
Main Authors: Gesine Meyer-Rath, Kathryn Schnippel, Lawrence Long, William MacLeod, Ian Sanne, Wendy Stevens, Sagie Pillay, Yogan Pillay, Sydney Rosen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3365041?pdf=render

Internet

http://europepmc.org/articles/PMC3365041?pdf=render

Similar Items